Related Experiment Video
Updated: Nov 9, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
606
Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management
Bob G Schultz1, Jessica Tilton2, Julie Jun2
1Pharmacy Systems, Outcomes, and Policy, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois, USA.
Summary
Pharmacist-led medication therapy management (MTM) clinics are cost-effective for preventing cardiovascular disease in hypertension patients. Current reimbursement rates undervalue these services, necessitating new models to support pharmacist-led care.
Area of Science:
- Health Economics
- Cardiovascular Disease Prevention
- Pharmacist-led Interventions
Background:
- Uncontrolled hypertension significantly contributes to cardiovascular disease (CVD), the leading cause of death and expense in the US.
- Pharmacists offer accessible clinical expertise for improving hypertension management via medication therapy management (MTM).
- Existing reimbursement structures do not adequately incentivize pharmacists to provide these crucial clinical services.
Purpose of the Study:
- To assess the cost-effectiveness of a pharmacist-led MTM clinic versus no clinic for 10-year primary prevention of stroke and CVD events in hypertensive patients.
- To inform healthcare policy regarding pharmacist MTM service reimbursement.
Main Methods:
- A semi-Markov model was developed from a payer's perspective to compare clinical and economic outcomes.
- Model data were derived from a controlled observational study on MTM clinic effectiveness.
- Methodology adhered to recommendations from the Second Panel on Cost-Effectiveness in Health and Medicine, including sensitivity analyses.
Main Results:
- The pharmacist-led MTM clinic demonstrated cost-effectiveness, yielding an incremental cost-effectiveness ratio of $38,798 per quality-adjusted life year (QALY) gained.
- An incremental net monetary benefit of $993,294 was observed at a $100,000 per QALY willingness-to-pay threshold.
- Achieving health-benefit benchmarks at $100,000-$150,000 per QALY would require a 95%-170% increase in current MTM reimbursement rates.
Conclusions:
- Pharmacist-led MTM services provide significant value to US payers, exceeding current reimbursement levels.
- The study highlights the need for revised reimbursement models to enable pharmacists to deliver cost-effective clinical care.
- Implementing adequate reimbursement is crucial for leveraging pharmacists' potential in managing chronic diseases like hypertension.
Related Concept Videos
01:23Hypertension V: Nursing Management
127
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
127
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
239
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
239
01:26Atherosclerosis III: Management
98
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
98
01:28Drug Therapy
140
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
140
01:29Therapeutic Drug Monitoring: Affecting Factors
55
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
55
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
186
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
186